Concepedia

Kerren K. Swinger

KK

Statistics

Publications

19

Citations

2.1K

H-Index

18

Active since

2003

Affiliations

Ribon Therapeutics (United States)(Current)

University of Chicago

Epizyme (United States)

Northwestern University

AbbVie (United States)

Kerren K. Swinger is an author at Ribon Therapeutics (United States) specializing in life sciences, molecular biology, and drug discovery.

Publications per year

2003–2022

19

Publications

19

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 347 citations · Full text

, , +7

Structure of a bacterial ribonuclease P holoenzyme in complex with tRNA

Nicholas J. Reiter, Amy Osterman, Alfredo Torres‐Larios et al. · Nature · 2010 · 298 citations · Full text

, , +12

Flexible DNA bending in HU–DNA cocrystal structures

Kerren K. Swinger, Kathryn M. Lemberg, Ying Zhang et al. · The EMBO Journal · 2003 · 256 citations · Full text

, , +11

Crystal structure of the RNA component of bacterial ribonuclease P

Alfredo Torres‐Larios, Kerren K. Swinger, Andrey S. Krasilnikov et al. · Nature · 2005 · 212 citations

, , +15

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity

Joseph M. Gozgit, Melissa M. Vasbinder, Ryan Abo et al. · Cancer Cell · 2021 · 183 citations

, , +14

1–5 of 19